Lindis Blood Care, a company aiming to set a new standard for blood management during cancer surgeries with its medical device CATUVAB ® , is pleased to announce the formation of its Scientific Advisory Board (“SAB”) comprising world-leading experts and key opinion leaders in the field of perioperative patient care, de-risking operative interventions, blood management and regulatory affairs.